vi-va
SENIOR MEMBER
- Joined
- Jan 23, 2019
- Messages
- 6,475
- Reaction score
- 3
- Country
- Location
Denmark and Norway Suspend AstraZeneca Covid-19 Vaccine Over Blood Clot Worries
European regulators are investigating reports of severe blood clots in people who have received doses
The Science Behind Why New Covid Variants Are Spreading Faster
0:00 / 7:01
The Science Behind Why New Covid Variants Are Spreading Faster
As highly transmissible coronavirus variants sweep across the world, scientists are racing to understand why these new versions of the virus are spreading faster, and what this could mean for vaccine efforts. New research says the key may be the spike protein, which gives the coronavirus its unmistakable shape.
Denmark, Norway and Iceland temporarily halted the use of the Covid-19 vaccine made by AstraZeneca PLC as a precaution, as they and other European regulators investigated reports of severe blood clots in people who have received doses.
Millions of doses of the shot have been administered across the continent. Europe’s top medicines watchdog said this week it hadn’t found instances of serious blood clots to be more common among people who got the AstraZeneca vaccine than in the general population.
Still, the Danish Health Authority said Thursday it would pause for at least two weeks the use of the AstraZeneca vaccine, which was developed with the University of Oxford. The pause includes for people who have already had their first dose of the two-dose vaccine.
Danish officials cited an unspecified number of reports of severe cases of blood clots in people who received the vaccine, including one person in Denmark who died. “It cannot be concluded whether there is a link between the vaccine and the blood clots,” the Danish health authority said.
Norway cited Denmark’s decision, saying it also doesn’t have evidence to connect the health incidents to vaccination but was acting out of caution to halt use of the AstraZeneca vaccine. Iceland also cited the cases in Denmark for its suspension.
www.wsj.com
European regulators are investigating reports of severe blood clots in people who have received doses
The Science Behind Why New Covid Variants Are Spreading Faster
0:00 / 7:01
The Science Behind Why New Covid Variants Are Spreading Faster
As highly transmissible coronavirus variants sweep across the world, scientists are racing to understand why these new versions of the virus are spreading faster, and what this could mean for vaccine efforts. New research says the key may be the spike protein, which gives the coronavirus its unmistakable shape.
Denmark, Norway and Iceland temporarily halted the use of the Covid-19 vaccine made by AstraZeneca PLC as a precaution, as they and other European regulators investigated reports of severe blood clots in people who have received doses.
Millions of doses of the shot have been administered across the continent. Europe’s top medicines watchdog said this week it hadn’t found instances of serious blood clots to be more common among people who got the AstraZeneca vaccine than in the general population.
Still, the Danish Health Authority said Thursday it would pause for at least two weeks the use of the AstraZeneca vaccine, which was developed with the University of Oxford. The pause includes for people who have already had their first dose of the two-dose vaccine.
Danish officials cited an unspecified number of reports of severe cases of blood clots in people who received the vaccine, including one person in Denmark who died. “It cannot be concluded whether there is a link between the vaccine and the blood clots,” the Danish health authority said.
Norway cited Denmark’s decision, saying it also doesn’t have evidence to connect the health incidents to vaccination but was acting out of caution to halt use of the AstraZeneca vaccine. Iceland also cited the cases in Denmark for its suspension.
Denmark and Norway Suspend AstraZeneca Covid-19 Vaccine Over Blood Clot Worries
Several European nations temporarily halted the use of the vaccine as a precaution as regulators investigated reports of severe blood clots in people who have received doses.
www.wsj.com
